4//SEC Filing
NxStage Medical, Inc. 4
Accession 0001246360-16-006027
CIK 0001333170operating
Filed
May 26, 8:00 PM ET
Accepted
May 27, 5:14 PM ET
Size
10.1 KB
Accession
0001246360-16-006027
Insider Transaction Report
Form 4
Giannini Daniel A
Director
Transactions
- Tax Payment
Common Stock
2016-05-25$18.81/sh−13,807$259,710→ 63,973 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-05-25−14,000→ 0 totalExercise: $18.55From: 2011-05-26Exp: 2016-05-25→ Common Stock (14,000 underlying) - Exercise/Conversion
Common Stock
2016-05-25$18.55/sh+14,000$259,700→ 77,780 total - Award
Stock Option (Right to Buy)
2016-05-26+15,854→ 15,854 totalExercise: $18.32From: 2016-06-26Exp: 2023-05-25→ Common Stock (15,854 underlying)
Footnotes (1)
- [F1]The stock option becomes exercisable in 12 equal monthly installments beginning June 26, 2016.
Documents
Issuer
NxStage Medical, Inc.
CIK 0001333170
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001333170
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 5:14 PM ET
- Size
- 10.1 KB